JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3085
CAS [1202402-40-1]
MF C20H21N7O3MW 407.43
CPI-444 is potent, selective and oral A2A adenosine receptor (A2aR) antagonist inhibitor (Ki value of 3.5 nM) which has demonstrated high selectivity and ability to block A2aR in in vitro studies. CPI-444 dramatically enhances immunologic responses in models of checkpoint therapy and ACT in cancer. Moreover, CPI-444 induces antitumor responses and augments efficacy to anti-PD-(L)1 and anti-CTLA-4 in preclinical models.
KEYWORDS: CPI-444 | supplier | A2A antagonist | Ciforadenant | V 81444 | CPI444 | CPI 444 | V81444 | V-81444 | CAS [1202402-40-1] | Adenosine | A2A | Antagonist | Receptors
(S)-7-(5-Methylfuran-2-yl)-3-((6-((tetrahydrofuran-3-yloxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
[1202402-40-1]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields